8,699
Views
1
CrossRef citations to date
0
Altmetric
Respiratory Medicine

Mortality risk reduction with budesonide/glycopyrrolate/formoterol fumarate versus fluticasone furoate/umeclidinium/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT

, , , , , , , , , , , , & show all
Pages 1395-1405 | Received 19 Jul 2023, Accepted 10 Aug 2023, Published online: 29 Aug 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (1)